• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUMENIS, INC. SELECTA DUET; POWERED LASER SURGICAL INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUMENIS, INC. SELECTA DUET; POWERED LASER SURGICAL INSTRUMENT Back to Search Results
Model Number SELECTA DUET
Device Problem Unexpected Therapeutic Results (1631)
Patient Problem Macular Edema (1822)
Event Date 05/09/2018
Event Type  Injury  
Manufacturer Narrative
A user facility reported that one (1) patient developed a macular edema in the right eye following a yag capsulotomy procedure with a lumenis selecta duet system.It was further reported that pred forte was prescribed for post-operative management.Lumenis investigated the reported event by contacting the user facility to obtain patient information, treatment settings and patient photos which were provided by the user facility.An examination of the subject device by a lumenis technical expert concluded, after verifying all system functions including calibration and energy output verification that the subject device operated within manufacturer's specifications.No device malfunction was reported or observed.Subject device malfunction is not the cause of the reported event.A lumenis healthcare professional spoke with the user facilities physician directly over the phone and reviewed the reported event.The following conclusions were noted; 1.In yag mode, direct damage to the retina is prevented by the large cone angle of the treatment beam (16 degree) and by plasma formation posterior to the site of optical breakdown.The only way a treatment beam could cause direct retinal damage is if the laser was used in slt mode.Since the physician confirmed that the laser was used in yag mode at all times, this possibility can be ruled out.2.As noted in the operator manual, there are known risks involved in yag laser posterior capsulotomy.Some of these risks include cystoid macular edema (cme), which could be relevant to the current incident.In several clinical studies, the incidence of cme was up to 2%.Cme could be caused by various mechanisms, including vitreous liquefaction and traction.Retinal detachment, which was also observed in up to 2% of cases, could trigger retinal breaks - also relevant to this case.3.One of the key factors for a successful yag capsulotomy free of retinal complications is protection of the anterior hyaloid face.Anterior hyaloid damage (ahd) during yag capsulotomy is associated with a range of retinal complications, including macular edema, retinal breaks, retinal holes, and retinal detachment.In one study, the rate of ahd was close to 20%.The authors noted that "ahd may be due to high pulse energy, high pulse number, carelessness, time limitations, issues related to focus of the beam on the posterior capsule, or inexperience".While pulse energy/pulse number are adequate, and carelessness/time limitations/inexperience are not likely, "issues related to focusing of the beam on the posterior capsule" could be relevant to this case.See the next bullet point.4.In this incident, the yag posterior capsulotomy was performed without a contact lens.While some physicians with extensive experience do perform this procedure with no contact lens, one should keep in mind that the use of a contact lens is important for many reasons, two of which could be relevant to this case: i.Optimizing the view of the posterior capsule: one of the key factors in anterior hyaloid disruption (ahd) is focusing the yag beam too posteriorly.Use of a contact lens, to obtain a clear view of the posterior capsule, could minimize this risk.Ii.Stabilization of the eye: inadvertent movements of the eye, especially rapid saccades, are much faster than the reaction time of a typical physician.Eye movement during lasing can damage non-target ocular tissues, for example (but not limited to) the anterior hyaloid face.Use of a contact lens, here as well, could minimize this risk.A review of the dhr confirmed that the system device met all test specifications without deviation per the dhr during the manufacturing process.
 
Event Description
A user facility reported that one (1) patient developed a macular edema in the right eye following a yag capsulotomy procedure with a lumenis selecta duet system.It was further reported that pred forte was prescribed for post-operative management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SELECTA DUET
Type of Device
POWERED LASER SURGICAL INSTRUMENT
Manufacturer (Section D)
LUMENIS, INC.
1870 south milestone dr.
salt lake city UT 84104
Manufacturer (Section G)
LUMENIS, INC.
1870 south milestone dr.
salt lake city UT 84104
Manufacturer Contact
gary buzzell
2077 gateway place
suite 300
san jose, CA 95110
4087643008
MDR Report Key7695614
MDR Text Key114220165
Report Number1720381-2018-00003
Device Sequence Number0
Product Code HQF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081704
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial
Report Date 07/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/17/2018
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model NumberSELECTA DUET
Device Catalogue NumberGAS910000
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/20/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/30/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age56 YR
-
-